AGER and Obesity: Advanced glycation end products (AGEs) interact with the receptor for advanced glycation end products (RAGE), expressed in adipocytes, to be involved in the progression of obesity, correlating with adipose tissue inflammation, adipocyte hypertrophy, and insulin sensitivity [3–5].